Company News for May 18, 2011 - Corporate Summary
May 18 2011 - 5:10AM
Zacks
• Dell Inc. (NASDAQ:DELL) reported Q1 EPS of
$0.55, higher than the Zacks Consensus Estimate of $0.43 per share.
Revenue for the quarter edged up 1% year-over-year to $15.02
billion, falling short of the Zacks Consensus Estimate of $15.457
billion
• Share prices of US listed Allied Irish Banks,
PLC. (NYSE:AIB) rose 13.33% to close at $3.06 after the banking
company unveiled a new structure and top management team
• Leerink Swann initiated coverage on shares of
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) with an "Outperform"
rating and a valuation call of $12 to $14 per share
• Share prices of elong, Inc. (NASDAQ:LONG)
increased 56.72% on news that China‘s Tencent Holdings has bought a
16% stake in the company for $84.4 million
• Shares of FairPoint Communications, Inc.
(NASDAQ:FRP) fell more than 40% to close at $9.59. Although the
company posted first quarter profits, its revenues were flat
compared to the prior year
• Analysts at Madison Williams initiated coverage
on Linn Energy, LLC (NASDAQ:LINE) with a “Buy” rating and a target
price of $45.00
• Analysts at Goldman Sachs (NYSE:GS) initiated
coverage on MAKO Surgical (NASDAQ:MAKO) with a “Buy” rating
• Analysts at Boenning & Scattergood
initiated coverage on Nektar Therapeutics (NASDAQ:NKTR) with an
“Outperform” rating and a target price of $15.00
• Analysts at Oppenheimer analysts initiated
coverage on Oncolytics Biotech, Inc. (NASDAQ:ONCY) setting a
“perform” rating
• Analysts at ThinkEquity initiated coverage on
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) with a “Buy” rating and
a target price of $18.00
ALLIED IRISH BK (AIB): Free Stock Analysis Report
ANTHERA PHARMA (ANTH): Free Stock Analysis Report
DELL INC (DELL): Free Stock Analysis Report
GOLDMAN SACHS (GS): Free Stock Analysis Report
LINN ENERGY LLC (LINE): Free Stock Analysis Report
ELONG INC-ADR (LONG): Free Stock Analysis Report
MAKO SURGICAL (MAKO): Free Stock Analysis Report
NEKTAR THERAP (NKTR): Free Stock Analysis Report
ONCOLYTICS BIO (ONCY): Free Stock Analysis Report
OPTIMER PHARMAC (OPTR): Free Stock Analysis Report
Zacks Investment Research
Elong ADS Representing 2 Ordinary Shares (MM) (NASDAQ:LONG)
Historical Stock Chart
From Sep 2024 to Oct 2024
Elong ADS Representing 2 Ordinary Shares (MM) (NASDAQ:LONG)
Historical Stock Chart
From Oct 2023 to Oct 2024